Service
Shaanxi Weishino Biotechnology Co., Ltd. was established in December 2021, located in the Science and Technology Enterprise Accelerator Park of Xi'an High tech Zone, Shaanxi Province. At present, we have 10 full-time and part-time R&D personnel, and have hired 6 R&D consultants from well-known domestic universities. Our main focus is on the design, synthesis, and application research of nucleic acid nanomaterials, and we are committed to building a qualitative and quantitative detection platform based on nucleic acid nanotechnology. We are dedicated to the research and development of disease early screening, diagnosis, and treatment technologies. The company currently has a molecular biology laboratory, a professional testing room, and a 10000 level ultra clean room, covering an area of approximately 1000 square meters. It is equipped with advanced instruments and equipment including a fluorescence quantitative PCR enzyme-linked immunosorbent assay (ELISA) reader, a chemiluminescence system, an ultra micro UV spectrophotometer, a biosafety cabinet, an ultra clean bench, a cell counter, a fluorescence inverted microscope, a flow cytometer, and a nanoparticle potential analyzer.
The company adheres to the core values of "caring for the world and benefiting the public", adheres to the business philosophy of talent as the guide and technology as the foundation, and strives to take "exploring the best solutions for the future health of humanity" as its responsibility. Under the leadership of the core team, it strives to be a pioneer in the field of early screening, diagnosis, and treatment of diseases, and is committed to providing personalized health protection for everyone and every family through biological nanotechnology, so that biological nanotechnology can benefit the whole society.
